Simeon J. George - Partner

Simeon joined SR One in 2007 and leads SR One's investment activities on the West Coast. Simeon serves as a member of the Board of Directors of Anaphore, Genocea Biosciences, HTG Molecular, Principia, Semprus BioSciences and as an observer at Rib-X. Prior to joining SR One, Simeon was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. Simeon earned his M.D. degree from the University of Pennsylvania School of Medicine and his M.B.A. degree from the Wharton School of Business, where he was a Mayer Scholar. He holds a B.A. in Neuroscience from the Johns Hopkins University, where he graduated Phi Betta Kappa.

 
Aileron    Alios    Locus Pharmaceuticals